AZN compared with EQT: revenue, margins and what each company keeps, and the suppliers and customers both name

AZNAstrazeneca PLC

Mkt capRevenueRevenue

EQTEQT Corp

Mkt capRevenueRevenue

Compare

AZNAstrazeneca PLC

EQTEQT Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AZN

No earnings history for AZN.

EQT

2 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 28 '26±5.2%▼−0.09%×0.02

Q3 FY26±2.0%▼−3.09%×1.55

Jul 22 '26±3.6%▲+8.45%×2.33

Q2 FY26±2.9%▼−1.12%×0.38

= impliedAZN realized, solidEQT realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

AZNAstrazeneca PLC

186.20▼−0.35%· post 187.60

Mkt cap$289.1BRevenue—Revenue—

EQTEQT Corp

49.40▼−2.41%· post 49.60

ClosedNov 6 '26

Mkt cap$30.9BRevenue$1.8BQ3 FY26Revenue$8.6BFY25

Compare

ClosedNov 6 '26

AZNAstrazeneca PLC

EQTEQT Corp

186.20▼−0.35%post 187.60

Price

49.40▼−2.41%post 49.60

$289.1B

Mkt cap

$30.9B

—

Revenue

$1.8BQ3 FY26

—

Revenue

$8.6BFY25

AZN186.20▼−0.35%vsEQT49.40▼−2.41%ClosedNov 6 '26